Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (FRA:FDY)

Germany flag Germany · Delayed Price · Currency is EUR
0.2580
-0.0020 (-0.77%)
Last updated: Jun 3, 2026, 8:06 AM CET
Market Cap722.45M -7.9%
Revenue (ttm)82.35M -11.7%
Net Income-19.16M
EPS-0.02
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.2580
Previous Close0.2600
Day's Range0.2580 - 0.2580
52-Week Range0.2560 - 0.3660
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About FRA:FDY

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China. It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technology drugs. The company was founded in 1996 and is based in Shanghai, the People's Republic of China. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1996
Employees 876
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol FDY

Financial Performance

Financial numbers in CNY Financial Statements